Royalty Pharma Sub-Manager, LLC
Holdings as of 2026-06-30, filed 2026-08-21
This is history, not a current position. These holdings describe 2026-06-30, and the report became public 52 days later. The portfolio has changed since.
Aggregates
computed from the positions belowPositions reported
4
Value reported by manager
$241.9M
Sum of our stored positions
$241.9M
should match the line above
Disclosure lag
52 d
quarter end to filing
Top 5 concentration
100.0%
of the positions shown
New positions
1
vs previous quarter
Exited
1
vs previous quarter
Option positions
0
puts and calls
Positions
4 largest shown| Issuer | Class | Value | Shares | Type | CUSIP |
|---|---|---|---|---|---|
| CYTOKINETICS, INC | COM | $83.5M | 980,392 | — | 23282W605 |
| ZENAS BIOPHARMA, INC. | COM | $60.6M | 2,388,150 | — | 98937L105 |
| KAILERA THERAPEUTICS | COM | $54.1M | 2,455,357 | — | 482931102 |
| BIOHAVEN LTD | COM | $43.7M | 2,936,507 | — | G1110E107 |
Values are shown exactly as filed. Before 2023 managers reported in thousands of dollars and afterwards in whole dollars; the reporting unit is not always determinable from the document, so nothing is converted automatically.
Source: U.S. Securities and Exchange Commission, Form 13F · as of 2026-08-21